Correlation Between Organogenesis Holdings and Cyclo Therapeutics
Can any of the company-specific risk be diversified away by investing in both Organogenesis Holdings and Cyclo Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Organogenesis Holdings and Cyclo Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Organogenesis Holdings and Cyclo Therapeutics, you can compare the effects of market volatilities on Organogenesis Holdings and Cyclo Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Organogenesis Holdings with a short position of Cyclo Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Organogenesis Holdings and Cyclo Therapeutics.
Diversification Opportunities for Organogenesis Holdings and Cyclo Therapeutics
-0.06 | Correlation Coefficient |
Good diversification
The 3 months correlation between Organogenesis and Cyclo is -0.06. Overlapping area represents the amount of risk that can be diversified away by holding Organogenesis Holdings and Cyclo Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cyclo Therapeutics and Organogenesis Holdings is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Organogenesis Holdings are associated (or correlated) with Cyclo Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cyclo Therapeutics has no effect on the direction of Organogenesis Holdings i.e., Organogenesis Holdings and Cyclo Therapeutics go up and down completely randomly.
Pair Corralation between Organogenesis Holdings and Cyclo Therapeutics
Given the investment horizon of 90 days Organogenesis Holdings is expected to generate 0.83 times more return on investment than Cyclo Therapeutics. However, Organogenesis Holdings is 1.2 times less risky than Cyclo Therapeutics. It trades about 0.02 of its potential returns per unit of risk. Cyclo Therapeutics is currently generating about -0.01 per unit of risk. If you would invest 413.00 in Organogenesis Holdings on August 31, 2024 and sell it today you would lose (26.00) from holding Organogenesis Holdings or give up 6.3% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Organogenesis Holdings vs. Cyclo Therapeutics
Performance |
| Timeline |
| Organogenesis Holdings |
| Cyclo Therapeutics |
Organogenesis Holdings and Cyclo Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Organogenesis Holdings and Cyclo Therapeutics
The main advantage of trading using opposite Organogenesis Holdings and Cyclo Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Organogenesis Holdings position performs unexpectedly, Cyclo Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cyclo Therapeutics will offset losses from the drop in Cyclo Therapeutics' long position.The idea behind Organogenesis Holdings and Cyclo Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| Cyclo Therapeutics vs. cbdMD Inc | Cyclo Therapeutics vs. Gelteq Limited Ordinary | Cyclo Therapeutics vs. cbdMD Inc | Cyclo Therapeutics vs. Harrow Health |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Complementary Tools
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |